Skip to main content
SpringerLink
Log in

CD38 and CD157: Biological Observations to Clinical Therapeutic Targets

  • Proceedings
  • Published:
Molecular Medicine Aims and scope Submit manuscript

Abstract

The application of molecular knowledge for developing new medical technologies is the goal of molecular medicine. Success in this area is highly dependent on the interaction of investigators from fields as diverse as biochemistry, cell biology, immunology, physiology, epidemiology, and physics, with an eye toward applying their insights and discoveries to improving human health. Such interdisciplinary approaches rarely find the common ground and language necessary to achieve this goal. Recently, a meeting of researchers studying the ectoenzymes CD38 and CD157 brought together insights into the regulation of calcium signaling, the metabolism of pyridine nucleotides by CD38 and CD157, and subsequent effects on immune function. Together, these discoveries were being applied to the development of novel therapeutics and diagnostics for myeloma and chronic lymphocytic leukemia. This issue of Molecular Medicine, featuring several short reviews based on a conference held in Turin, Italy, 10–12 June 2006, showcases the current state of this field and highlights some recent progress in molecular medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References

  1. Zola H. (2006) Medical applications of leukocyte surface markers: the CD molecules. Mol Med 12(11–12) In press

  2. Malavasi F, et al. (2006) CD38 and CD157 as receptors of the immune system. Mol Med 12(11–12) In press

  3. Lund F. (2006) Signaling properties of CD38 in the mouse immune system: enzyme-dependent and independent roles in immunity. Mol Med 12(11–12) In press

  4. Lee HC. (2006) Structure and enzymatic functions of human CD38. Mol Med 12(11–12) In press

  5. Billington RA et al. (2006) Emerging functions of extracellular pyridine nucleotides. Mol Med 12(11–12) In press

  6. Morabito F et al. (2006) The CD38 ectoenzyme facily: advances in basic science and clinical practice. Mol Med 12(11–12) In press

  7. Stevenson GT. (2006) CD38 as a therapeutic target. Mol Med 12(11–12) In press

Download references

Acknowledgments

The authors thank Dr. Silvia Deaglio, Department of Genetics, Biology and Biochemistry, University of Torino, Italy, for assistance with preparing the figure.

Author information

Authors and Affiliations

  1. Department of Science and Mathematics, Suffolk County Community College Eastern Campus, 121 Speonk-Riverhead Road, Riverhead, NY, USA

    Amy Warenda Czura

  2. Laboratory of Biomedical Science, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, 11030, USA

    Christopher J Czura

Authors
  1. Amy Warenda Czura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher J Czura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher J Czura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Czura, A.W., Czura, C.J. CD38 and CD157: Biological Observations to Clinical Therapeutic Targets. Mol Med 12, 309–311 (2006). https://doi.org/10.2119/2007-00006.Czura

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2119/2007-00006.Czura

Search

Navigation